ZALICUS
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The Company has devoted substantially all of its resources to the development of its drug discovery technology and the research and development of its drug candidates, including conducting preclinical and clinical trials and seeking intellectual property protection for its technology and product candidates. On March 1, 2010... , the United States Food and Drug Administration, (FDA), approved the New Drug Application (NDA) for Exalgo (hydromorphone HCl) extended-release tablets, for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time. On December 21, 2009, the Company merged with Neuromed Pharmaceuticals, Inc. and its subsidiaries.
ZALICUS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2000-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.zalicus.com
Total Employee:
11+
Status:
Active
Contact:
6173017010
Total Funding:
84.98 M USD
Technology used in webpage:
Domain Not Resolving Amazon Amazon California Region
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Nocion Therapeutics
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-12-21 | Neuromed Pharmaceuticals | Neuromed Pharmaceuticals acquired by Zalicus | N/A |
Investors List
TL Ventures
TL Ventures investment in Series E - Zalicus
Flagship Pioneering
Flagship Pioneering investment in Series D - Zalicus
Easton Capital
Easton Capital investment in Series D - Zalicus
Global Life Science Ventures
Global Life Science Ventures investment in Series D - Zalicus
Canaan Partners
Canaan Partners investment in Series D - Zalicus
Yasuda Enterprise Development
Yasuda Enterprise Development investment in Series D - Zalicus
TL Ventures
TL Ventures investment in Series D - Zalicus
Boston Millennia Partners
Boston Millennia Partners investment in Series D - Zalicus
Canaan Partners
Canaan Partners investment in Series C - Zalicus
TL Ventures
TL Ventures investment in Series C - Zalicus
Official Site Inspections
http://www.zalicus.com
- Host name: ec2-13-56-33-8.us-west-1.compute.amazonaws.com
- IP address: 13.56.33.8
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Zalicus"
Zalicus - Crunchbase Company Profile & Funding
Zalicus Inc., formerly CombinatoRx, Incorporated, is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain and inflammation. The …See details»
Home - falicus.com
Per fornire le migliori esperienze, il sito Safety361.com utilizza tecnologie come i cookie per memorizzare e/o accedere alle informazioni del dispositivo. Il consenso a queste tecnologie ci …See details»
ZALICUS INC. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ZALICUS INC. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Zalicus Information - RocketReach
Zalicus discovers and develops innovative therapeutics for patients in need. We believe that our novel product candidates, productive drug discovery platforms, drug development expertise, …See details»
Zalicus 2025 Company Profile: Valuation, Investors, Acquisition
Information on acquisition, funding, cap tables, investors, and executives for Zalicus. Use the PitchBook Platform to explore the full profile.See details»
Zalicus - Company Profile - Tracxn
Feb 25, 2025 Zalicus - Developing therapeutics for treatment of pain and inflammation. Public Company. Raised a total funding of $30M over 2 rounds from 10 investors.See details»
Zalicus - LinkedIn
Zalicus | 243 followers on LinkedIn. Zalicus discovers and develops innovative therapeutics for patients in need. We believe that our novel product candidates, productive drug discovery …See details»
Zalicus Pharmaceuticals - Crunchbase Company Profile & Funding
Zalicus Pharmaceuticals operates as a biopharmaceutical company which develops chronic pain drugs.See details»
Zalicus - Funding, Financials, Valuation & Investors - Crunchbase
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.See details»
Zalicus Pharmaceuticals Company Profile 2024: Valuation
Information on acquisition, funding, investors, and executives for Zalicus Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Zalicus Inc: Shareholders Board Members Managers and Company …
Zalicus Inc: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nasdaq: | NasdaqSee details»
Zalicus - Ownership and Business Overview | Mergr
What sector is Zalicus in? Zalicus is a life science company.See details»
U.S. arm of Sun Pharma's Taro buys Zalicus Pharmaceuticals of …
Oct 14, 2015 The acquisition of Canada's Zalicus Pharmaceuticals by a U.S. subsidiary of India's largest drugmaker, Sun Pharmaceuticals, is being seen as a move to strengthen its …See details»
Zalicus Pharmaceuticals Ltd Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Zalicus Pharmaceuticals Ltd of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Zalicus | IT History Society
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.Zalicus Inc., formerly CombinatoRx, Incorporated, is a …See details»
Zalicus Pharmaceuticals - Ownership and Business Overview - Mergr
Who owns Zalicus Pharmaceuticals? Zalicus Pharmaceuticals is owned by Taro Pharmaceuticals. It was acquired on October 14, 2015.See details»
Zalicus Pharmaceuticals Ltd Company Profile, Financial and …
This report contains Zalicus Pharmaceuticals Ltd company and market share data which will help you understand the detailed picture of company’s financial position. In-depth analysis …See details»
Zalicus, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Zalicus, Inc. with its drug pipeline, therapeutic area, technology platform, 21 clinical trials, 15 news, and 40 literature, Disease Domain:Endocrinology and ...See details»
What is Zalicus Pharmaceuticals? Company Culture, Mission, Values
See what employees say it's like to work at Zalicus Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Zalicus Pharmaceuticals.See details»
Zalicus Inc. to Halt Further Clinical Development With Synavive
Sep 10, 2012 “In the absence of a clinically meaningful benefit with Synavive compared to its active glucocorticoid component, Zalicus will discontinue further clinical development with …See details»